OnabotulinumtoxinA for chronic migraine treatment: 75% responder analysis from double-blind, randomized, placebo-controlled phase of PREEMPT

The Journal of Headache and Pain

Poster Presentation

关键词: Placebo;    Migraine;    Chronic Migraine;    Parallel Study;    Responder Rate;   

DOI  :  10.1186/1129-2377-14-S1-P197

来源: Springer

【 授权许可】

CC BY   
© Dodick et al; licensee Springer. 2013. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.